Cite
HARVARD Citation
Sunami, K. et al. (2020). Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study. Cancer science. 111 (12), pp. 4526-4539. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sunami, K. et al. (2020). Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study. Cancer science. 111 (12), pp. 4526-4539. [Online].